Indicators of pathologic stage of prostate cancer and their use in clinical practice (Q34394816)

1 August 2017

1 reference

title

Indicators of pathologic stage of prostate cancer and their use in clinical practice (English)

1 reference

1 August 2017

1 reference

Feneley MR

1 reference

1 August 2017

Partin AW

series ordinal

1 reference

1 August 2017

publication date

1 August 2001

1 reference

Urologic Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

443-458

1 reference

Analysis of Risk Factors Associated with Prostate Cancer Extension to the Surgical Margin and Pelvic Node Metastasis at Radical Prostatectomy

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Assessment of the vascularization in prostatic carcinoma: a morphometric investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Staging of early prostate cancer: a proposed tumor volume-based prognostic index

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prediction of capsular perforation and seminal vesicle invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Assessment of screening for prostate cancer using the digital rectal examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Calculated prostate cancer volume: the optimal predictor of actual cancer volume and pathologic stage

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Predictive value of contralateral biopsies in unilaterally palpable prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Predictive accuracy of transrectal ultrasound-guided prostate biopsy: correlations to matched prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prognostic significance of seminal vesicle invasion on the radical prostatectomy specimen. Rationale for seminal vesicle biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Perineural invasion on prostate needle biopsy: an independent predictor of final pathologic stage

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Predictive value of the anatomical location of ultrasound-guided systematic sextant prostate biopsies for the nodal status of patients with localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prostate cancer sampled on sextant needle biopsy: significance of cancer on multiple cores from different areas of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Correlation of Prostate Cancer Nuclear Deoxyribonucleic Acid, Size, Shape and Gleason Grade with Pathological Stage at Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The significance of low-grade prostate cancer on needle biopsy. A radical prostatectomy study of tumor grade, volume, and stage of the biopsied and multifocal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Indications for transition zone biopsy in the detection of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Diagnostic and prognostic markers for human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The accuracy of the rectal examination in the diagnosis of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Systematic sextant biopsies in 651 patients referred for prostate evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: implications of RTOG data for patient management and trial design and stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Serum percent-free PSA does not predict extraprostatic spread of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Ultrasound guided transrectal core biopsies of the palpably abnormal prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Computer-assisted comparative analysis of four-sector and six-sector biopsies of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Outcome of sextant biopsy according to gland volume

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prostate cancer microvessels: a novel method for three-dimensional reconstruction and analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Screening for carcinoma of the prostate: a GP based study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Ability of preoperative serum prostatespecific antigen value to predict pathologic stage and DNA ploidy Influence of clinical stage and tumor grade

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The prostate: MR imaging and spectroscopy. Present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Extended Experience With Radical Prostatectomy for Clinical Stage T3 Prostate Cancer: Outcome and Contemporary Morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Vascular density is a predictor of cancer-specific survival in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The Clinical Usefulness of Prostate Specific Antigen: Update 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

A single positive prostate biopsy in six does not predict a low-volume prostate tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Microvessel density in core biopsies of prostatic adenocarcinoma: a stage predictor?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The European Randomized Study of Screening for Prostate Cancer (ERSPC): an update. Members of the ERSPC, Section Rotterdam

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Staging laparoscopic pelvic lymphadenectomy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Topography of neovascularity in human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Making the most out of six systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Large, Organ Confined, Impalpable Transition Zone Prostate Cancer: Association with Metastatic Levels of Prostate Specific Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Efficacy of transrectal ultrasound-guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

The influence of prostate size on cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Inter-observer variation in assessment of the prostate by digital rectal examination

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Invasion of Denonvilliers' fascia in radical prostatectomy specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Ability of sextant biopsies to predict radical prostatectomy stage

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

Comparison of nuclear morphometric results between needle biopsy and surgical specimens from patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970154-3

7 January 2021

10.1016/S0094-0143(05)70154-3

Identifiers

DOI

1 reference

1 August 2017

1 reference